| Home | E-Submission | Sitemap | Contact Us |  
J Korean Cancer Assoc > Volume 22(1); 1990 > Article
Journal of the Korean Cancer Association 1990;22(1): 112-116.
악성 임파종 MACOP - B 항암요법
이경식, 김훈교, 홍영선, 문한림, 한제호, 김치홍
MACOP - B Chemthrapy for the Treatment of Malignant Lymphoma
Kyung Shik Lee, Hoon Kyo Kim, Young Seon Hong, Han Lim Moon, Je Ho Han, Chi Hong Kim
Between September 1987 and April 198S, 18 patients with advanced aggressive non-Hodgkin's lymphoma completed treatment with MACOP-B (methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin). Among them, 14 patients were evaluable for the response and toxicity. Twelve patients (86%) achieved a complete response and 2 patients (14%,) had a partial response. The most frequent toxicity was leukopenia. Thus, MACOP-B is an effective and safe treatment for advanced aggressive lymphoma.
Key words: Malignant lymphoma, MACOP B chemotherapy
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI